IP Library Granted Patent US 8,268,582
Granted Patent B2
US 8,268,582 · App. 10/577,074 · Granted Sep 18, 2012

Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,268,582
App. No.
10/577,074
Granted
Sep 18, 2012
Kind
B2
Abstract

Methods are provided for the synthesis and secretion of recombinant hetero-multimeric proteins in mating competent yeast. A first expression vector is transformed into a first haploid cell; and a second expression vector is transformed into a second haploid cell. The transformed haploid cells, each individually synthesizing a non-identical polypeptide, are identified and then genetically crossed or fused. The resulting diploid strains are utilized to produce and secrete fully assembled and biologically functional hetero-multimeric protein.

Claims (34)

1. A method for the synthesis and recovery of a secreted, biologically active heterologous heteromultimeric polypeptide comprising at least two non-identical subunit polypeptide chains, the method comprising:

(i) producing one or more stable diploid Pichia cells by mating or fusing a first haploid Pichia cell containing a first expression construct, said first expression construct comprising nucleic acid sequences encoding for the expression of at least one subunit of said heteromultimeric polypeptide, operably linked to a first yeast promoter; and a second haploid Pichia cell containing a second expression construct, said second expression construct comprising nucleic acid sequences encoding for the remaining subunit(s) of said heteromultimeric polypeptide, operably linked to a second yeast promoter under conditions yielding one or more diploid Pichia cells, wherein said diploid cells comprise at least one expression construct encoding for at least two non-identical subunit polypeptide chains, and which stable diploid Pichia cells are capable of the assembly, expression and secretion of said heteropolymeric polypeptide which is comprised of said at least two non-identical subunit polypeptide chains into a culture medium when cultured in said medium under appropriate culture conditions;

(ii) culturing said diploid Pichia cells, or diploid progeny thereof, in a culture medium under conditions resulting in the expression, assembly and secretion of said biologically active heteromultimeric polypeptide in the culture medium; and

(iii) recovering the resultant heteromultimeric polypeptide from the culture medium, wherein the heteromultimeric polypeptide is an antibody or an antigen binding antibody fragment.

2. The method according to claim 1 , wherein said Pichia cells are selected from Pichia pastoris, Pichia methanolica , and Pichia angusta.

3. The method according to claim 2 , wherein said Pichia cells are Pichia pastoris.

4. The method of claim 1 , wherein said expression constructs are integrated into the genome of said diploid Pichia cells.

5. The method of claim 1 , wherein said expression constructs are contained on extrachromosomal elements.

6. The method of claim 1 , wherein the first or second promoters are constitutive.

7. The method of claim 1 , wherein the first or second promoters are inducible.

8. The method of claim 1 , wherein the diploid Pichia cells are grown in a production media.

9. The method of claim 8 , wherein said production media is a minimal media.

10. The method of claim 9 , wherein said minimal media lacks selective agents.

11. The method of claim 9 , wherein said minimal media lacks pre-formed amino acids or other complex biomolecules.

12. The method of claim 1 , wherein said diploid Pichia cells are grown to a cell density of at least about 50 g/L.

13. The method of claim 12 , wherein said cell density is at least about 100 g/L.

14. The method of claim 13 , wherein said cell density is at least about 300 g/L.

15. The method of claim 14 , wherein said cell density is at least about 400 g/L.

16. The method of claim 15 , wherein said cell density is at least about 500 g/L.

17. The method of claim 1 , wherein said diploid Pichia cells are grown under conditions resulting in levels of said biologically active heteromultimeric polypeptide in the culture medium which are at least about 50 mg/L.

18. The method of claim 17 , wherein said diploid Pichia cells are grown under conditions resulting in levels of said biologically active heteromultimeric polypeptide in the culture medium which are at least about 100 mg/L.

19. The method of claim 18 , wherein said diploid Pichia cells are grown under conditions resulting in levels of said biologically active heteromultimeric polypeptide in the culture medium which are at least about 500 mg/L.

20. The method of claim 19 , wherein said diploid Pichia cells are grown under conditions resulting in levels of said biologically active heteromultimeric polypeptide in the culture medium which are at least about 1000 mg/L.

21. The method of claim 1 , wherein at least about 99% of said diploid Pichia cells comprise said expression constructs after culturing for at least 20 doublings.

22. The method of claim 21 , wherein at least about 99% of said diploid Pichia cells comprise said expression constructs after culturing for at least 50 doublings.

23. The method of claim 22 , wherein at least about 99% of said diploid Pichia cells comprise said expression constructs after culturing for at least 100 doublings.

24. The method of claim 1 , wherein the diploid Pichia cells express the heteromultimeric polypeptide at a level of expression which is reduced by not more than about 20% relative to the starting level of expression after culturing for at least 20 doublings.

25. The method of claim 24 , wherein the diploid Pichia cells express the heteromultimeric polypeptide at a level of expression which is reduced by not more than about 20% relative to the starting level of expression after culturing for at least 50 doublings.

26. The method of claim 25 , wherein the diploid Pichia cells express the heteromultimeric polypeptide at a level of expression which is reduced by not more than about 20% relative to the starting level of expression after culturing for at least 100 doublings.

27. The method of claim 8 , wherein the diploid Pichia cells express the heteromultimeric polypeptide at a level of expression which is reduced by not more than about 10% relative to the starting level of expression after culturing for at least 20 doublings.

28. The method of claim 8 , wherein the diploid Pichia cells express the heteromultimeric polypeptide at a level of expression which is reduced by not more than about 5% relative to the starting level of expression after culturing for at least 20 doublings.

29. The method of claim 1 , wherein said culture containing said diploidal Pichia cells is grown at a temperature of not more than 22° C.

30. A culture medium containing a stable diploid Pichia culture according to claim 1 , wherein the culture medium comprises expression levels of said biologically active heteromultimeric polypeptide which are at least about 50 mg/liter.

31. A culture medium containing a stable diploid Pichia culture according to claim 1 , that expresses said heteromultimeric polypeptide into a culture medium, wherein the cell density of said Pichia diploid cells in said culture are at least about 50 g/L.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 054161 FRAME: 0877. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 2, 2021
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 056449/0543 →
CHANGE OF NAME Recorded Sep 3, 2020
From: ALDER BIOPHARMACEUTICALS, INC
To: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
Reel/Frame 053681/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S.
Reel/Frame 054161/0877 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2020
From: ALDERBIO HOLDINGS LLC
To: H. LUNDBECK A/S
Reel/Frame 053020/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2014
From: ALDER BIOPHARMACEUTICALS, INC.
To: ALDERBIO HOLDINGS LLC
Reel/Frame 032289/0791 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2006
From: CREGG, JAMES M.; LATHAM, JOHN; LITTON, MARK; SCHATZMAN, RANDALL; TOLSTORUKOV, ILYA I.
To: KECK GRADUATE INSTITUTE; ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 017805/0934 →